Skip to main content
. 2002 Oct 15;8(5):908–912. doi: 10.3748/wjg.v8.i5.908

Table 1.

Immunotherapeutic Effect of DCs Vaccine in Mice with Pancreatic Carcinoma

DC-IL18-Lysate I group DC-Lysate II group DC-IL18 III group DC IV group PBS V group
Tumor Weight (g) 0.22 ± 0.083a 1.45 ± 0.74bc 1.89 ± 1.34d 3.0 ± 1.6 2.9 ± 2.0
Median Survival (d) > 62a 48.6 ± 9.4bc 33 ± 12.3d 17 ± 3.2 19.6 ± 5.4
a

P < 0.01, vs the other groups;

b

P < 0.05, vs III group;

c

P < 0.01, vs IV and V groups;

d

P < 0.05, vs IV and V group